Adicet Therapeutics
Clinical trials sponsored by Adicet Therapeutics, explained in plain language.
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests a new treatment called Prula-cel for people with autoimmune diseases like lupus, scleroderma, and vasculitis. Prula-cel uses donor immune cells engineered to target and destroy faulty immune cells that attack the body. The goal is to find a safe dose …
Phase: PHASE1 • Sponsor: Adicet Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
15-Year watch begins for CAR t cell therapy patients
Knowledge-focused OngoingThis study follows 50 people who have already received an experimental CAR T cell therapy for certain blood cancers like lymphoma. No new treatment is given; instead, researchers will check for long-term side effects and how well the therapy works over 15 years. The goal is to be…
Sponsor: Adicet Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC